Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study

Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study

(2011) Herbert Y. Meltzer et al.   AMERICAN JOURNAL OF PSYCHIATRY

Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder

(2011) Steven G. Potkin et al.   SCHIZOPHRENIA RESEARCH

Findings of a U.S. National Cardiometabolic Screening Program Among 10,084 Psychiatric Outpatients

(2010) Christoph Correll   PSYCHIATRIC SERVICES

Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis

(2010) Christine Rummel-Kluge et al.   SCHIZOPHRENIA RESEARCH

Lurasidone in the Treatment of Acute Schizophrenia

(2009) Mitsutaka Nakamura et al.   JOURNAL OF CLINICAL PSYCHIATRY

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

(2008) Stefan Leucht et al.   LANCET

How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials

(2008) S Leucht et al.   MOLECULAR PSYCHIATRY

Antipsychotic-Induced Hyperprolactinemia

(2008) Jolene R Bostwick et al.   PHARMACOTHERAPY

Antipsychotic Use in the Treatment of Outpatients With Schizophrenia in the VA From Fiscal Years 1999 to 2006

(2008) M. J. Sernyak et al.   PSYCHIATRIC SERVICES